ALDH associated with worse overall survival in patients with pancreatic adenocarcinoma
Wednesday, February 17, 2010 - 16:42
in Health & Medicine
Expression of aldehyde dehydrogenase (ALDH) in pancreatic adenocarcinoma is associated with worse overall survival in patients who have undergone resection for early-stage disease, according to a new study published online February 17 in the Journal of the National Cancer Institute.